Showing results (1-10 of 1,343) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|July 2, 2022
The clinically relevant CYP2C8*3 and CYP2C9*2 haplotype is inherited from NeandertalsSigrid Haeggström, Magnus Ingelman-Sundberg, Svante Pääbo, et al.
The Pharmacogenomics Journal|June 16, 2021
Genetic-guided pharmacotherapy for venous thromboembolism: a systematic and critical review of economic evaluationsKa Keat Lim, Rositsa Koleva-Kolarova, Philip Chowienczyk, et al.
The Pharmacogenomics Journal|October 4, 2020
Genome-wide association study of cardiovascular disease in testicular cancer patients treated with platinum-based chemotherapyLars C Steggink, Hink Boer, Coby Meijer, et al.
The Pharmacogenomics Journal|October 7, 2020
Characterization of four BCHE mutations associated with prolonged effect of suxamethoniumXavier Brazzolotto, Sébastien Courcelle, Christophe Sauvanet, et al.
The Pharmacogenomics Journal|June 23, 2021
New genetic variants associated with major adverse cardiovascular events in patients with acute coronary syndromes and treated with clopidogrel and aspirinXiaomin Liu, Hanshi Xu, Huaiqian Xu, et al.
The Pharmacogenomics Journal|August 3, 2010
Assessment of variability in GWAS with CRLMM genotyping algorithm on WTCCC coronary artery diseaseL Zhang, S Yin, K Miclaus, et al.
The Pharmacogenomics Journal|July 21, 2010
A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancerA Ho-Pun-Cheung, E Assenat, C Bascoul-Mollevi, et al.
The Pharmacogenomics Journal|July 21, 2010
Effect of apolipoprotein E and butyrylcholinesterase genotypes on cognitive response to cholinesterase inhibitor treatment at different stages of Alzheimer's diseaseC E Patterson, S A Todd, A P Passmore
The Pharmacogenomics Journal|July 21, 2010
A new mouse mutant of the Cdh23 gene with early-onset hearing loss facilitates evaluation of otoprotection drugsF Han, H Yu, C Tian, et al.
The Pharmacogenomics Journal|August 11, 2010
Sequential changes in gene expression profiles in breast cancers during treatment with the aromatase inhibitor, letrozoleW R Miller, A Larionov, T J Anderson, et al.
Pageof 135